Portal de Periódicos da CAPES

The Effects of High and Low-Dose Cordyceps Militaris-Containing Mushroom Blend Supplementation After Seven and Twenty-Eight Days

2018; Science Publishing Group; Volume: 6; Issue: 1 Linguagem: Inglês

10.11648/j.ajss.20180601.11

2330-8540

Wesley D. Dudgeon,

Herbal Medicine Research Studies

The purpose of this study was to examine the aerobic performance effect of 1) low-dose mushroom blend supplementation (1.0 - 2.0 g/day) over a prolonged time period of 28 days compared to a placebo and 2) a higher dose of PeakO 2 (12 g/day) for seven days compared to placebo supplementation. For Trial 1, 40 young adult (19-34 yrs) subjects met participation criteria and were randomized into one of two groups. The treatment group (T, n=23) consumed 1.0-2.0 g /day of mushroom blend (PeakO 2 ) along with 2.0g of Gatorade powder for 28 days. The control group (C, n=17) consumed placebo (whole wheat flour) and Gatorade powder in identical fashion. At baseline each participant completed a maximal oxygen consumption (VO 2max ) test, which included a 5-minute economy state from minutes 3-8 along with a Wingate cycle ergometer test (peak power) at least 24 hrs later. Forty-three young adult subjects met participation criteria for Trial 2 and were randomized into one of two groups. T (n=29), consumed 12.0 g /day of mushroom blend (PeakO 2 ) along with 12.0 g of Gatorade powder for one week. C (n=14) consumed placebo (whole wheat flour) and Gatorade powder in identical fashion There were no differences between groups in any variables at baseline. After 28 days of supplementation, T had a significant increase (< 0.05) in time to fatigue, a significant increase in VO 2peak (p < 0.05) and a reduction in blood lactate (p < 0.05) during the economy phase. Analysis for trial 2 was conducted stratifying each group by VO 2peak at baseline, in which the top 50% of each group was compared to the bottom 50% (Treatment top, MT, Treatment bottom, MB, Control top, CT, Control bottom, CB). The MB group experienced significant (p<0.05) increases in VO 2peak . MB increased VO 2max significantly (p < 0.05) while MT, CT, and CB did not change significantly. The MT group experienced a significant 3 bpm drop in economy HR from pre- to post-testing (p < 0.05). The PT demonstrated a significant 4.5% increase in peak power from pre- to post-testing (p < 0.05). No other changes were detected. These data suggest that longer duration, lower dose, supplementation of PeakO 2 appears to improve endurance performance in apparently healthy young adults. Further, short duration supplementation of higher doses of PeakO 2 may improve performance, but differing effects may occur based upon fitness level.